Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
B-Lymphocytes | 6 | 2021 | 4418 | 1.25 | Why? |
Gastric Mucosa | 1 | 2018 | 141 | 0.68 | Why? |
Receptors, Antigen, T-Cell | 2 | 2018 | 760 | 0.59 | Why? |
Immunoglobulin E | 1 | 2018 | 557 | 0.58 | Why? |
Food Hypersensitivity | 2 | 2018 | 397 | 0.51 | Why? |
Antibodies, Viral | 10 | 2021 | 51949 | 0.47 | Why? |
Allergens | 1 | 2018 | 728 | 0.47 | Why? |
Antibodies | 1 | 2018 | 846 | 0.45 | Why? |
Intestinal Mucosa | 1 | 2018 | 1046 | 0.42 | Why? |
Adaptive Immunity | 2 | 2021 | 2585 | 0.41 | Why? |
Immunologic Memory | 1 | 2021 | 3362 | 0.37 | Why? |
Immunoglobulin D | 1 | 2021 | 24 | 0.23 | Why? |
Genes, Immunoglobulin | 1 | 2021 | 50 | 0.23 | Why? |
Dialysis | 1 | 2021 | 45 | 0.23 | Why? |
Immunoglobulin Class Switching | 1 | 2021 | 133 | 0.22 | Why? |
Immunogenetics | 1 | 2020 | 124 | 0.21 | Why? |
Immunoglobulin G | 6 | 2021 | 21571 | 0.21 | Why? |
Somatic Hypermutation, Immunoglobulin | 1 | 2021 | 283 | 0.21 | Why? |
Palatine Tonsil | 1 | 2021 | 127 | 0.20 | Why? |
Immunoglobulin Heavy Chains | 1 | 2021 | 222 | 0.20 | Why? |
Cross Reactions | 2 | 2021 | 4374 | 0.20 | Why? |
Bartonella | 1 | 2018 | 24 | 0.19 | Why? |
V(D)J Recombination | 1 | 2018 | 16 | 0.19 | Why? |
Enzyme-Linked Immunosorbent Assay | 4 | 2021 | 7868 | 0.18 | Why? |
Receptors, Antigen, B-Cell | 1 | 2021 | 424 | 0.18 | Why? |
Sequence Analysis | 1 | 2020 | 496 | 0.18 | Why? |
Fluorescent Antibody Technique | 1 | 2021 | 835 | 0.18 | Why? |
Immunity, Mucosal | 1 | 2021 | 426 | 0.17 | Why? |
Fetal Blood | 1 | 2021 | 573 | 0.17 | Why? |
Receptors, IgG | 1 | 2020 | 578 | 0.16 | Why? |
Spleen | 1 | 2021 | 877 | 0.16 | Why? |
Mammals | 1 | 2018 | 315 | 0.16 | Why? |
Nucleocapsid | 1 | 2021 | 734 | 0.16 | Why? |
Food | 1 | 2018 | 316 | 0.15 | Why? |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 526 | 0.15 | Why? |
Vaccination | 1 | 2021 | 19050 | 0.15 | Why? |
Systems Biology | 1 | 2018 | 320 | 0.14 | Why? |
Spike Glycoprotein, Coronavirus | 7 | 2021 | 37182 | 0.14 | Why? |
Vaccines, Subunit | 1 | 2021 | 1088 | 0.14 | Why? |
Adjuvants, Immunologic | 2 | 2021 | 1709 | 0.14 | Why? |
Lymph Nodes | 1 | 2021 | 1060 | 0.13 | Why? |
Ebolavirus | 1 | 2021 | 834 | 0.13 | Why? |
Plasma | 2 | 2021 | 1809 | 0.13 | Why? |
Immune Tolerance | 1 | 2018 | 608 | 0.13 | Why? |
Severity of Illness Index | 2 | 2020 | 48226 | 0.13 | Why? |
Coronavirus | 1 | 2021 | 18339 | 0.11 | Why? |
HLA Antigens | 1 | 2017 | 830 | 0.11 | Why? |
Seroepidemiologic Studies | 3 | 2021 | 10017 | 0.11 | Why? |
Autoimmunity | 1 | 2018 | 841 | 0.11 | Why? |
Immune Evasion | 1 | 2021 | 2081 | 0.10 | Why? |
Blood Donors | 2 | 2021 | 2956 | 0.10 | Why? |
High-Throughput Nucleotide Sequencing | 2 | 2021 | 3633 | 0.10 | Why? |
Immunity | 1 | 2021 | 2651 | 0.10 | Why? |
Disease Reservoirs | 1 | 2018 | 1672 | 0.10 | Why? |
Immunoglobulin A | 1 | 2020 | 3567 | 0.09 | Why? |
Aged, 80 and over | 5 | 2021 | 88759 | 0.09 | Why? |
Protein Domains | 1 | 2021 | 6563 | 0.09 | Why? |
Hypersensitivity | 1 | 2018 | 1137 | 0.09 | Why? |
Antibodies, Neutralizing | 4 | 2021 | 25288 | 0.08 | Why? |
T-Lymphocytes | 2 | 2021 | 6670 | 0.08 | Why? |
Antibody Formation | 1 | 2020 | 4038 | 0.08 | Why? |
HEK293 Cells | 1 | 2020 | 8394 | 0.08 | Why? |
Proteomics | 1 | 2018 | 2481 | 0.08 | Why? |
Gene Expression Profiling | 1 | 2018 | 3788 | 0.08 | Why? |
Genomics | 1 | 2018 | 3118 | 0.07 | Why? |
Adult | 10 | 2021 | 244371 | 0.07 | Why? |
Middle Aged | 10 | 2021 | 270681 | 0.07 | Why? |
Aged | 8 | 2021 | 215776 | 0.07 | Why? |
Humans | 21 | 2021 | 930598 | 0.07 | Why? |
Aging | 1 | 2021 | 3581 | 0.07 | Why? |
Male | 13 | 2021 | 367725 | 0.07 | Why? |
Influenza Vaccines | 1 | 2021 | 2941 | 0.07 | Why? |
Real-Time Polymerase Chain Reaction | 2 | 2020 | 11367 | 0.07 | Why? |
Disease Models, Animal | 2 | 2021 | 10998 | 0.07 | Why? |
Genetic Variation | 1 | 2018 | 3919 | 0.07 | Why? |
Renal Dialysis | 1 | 2021 | 4358 | 0.07 | Why? |
Immunoglobulin M | 1 | 2021 | 9091 | 0.06 | Why? |
Immunity, Innate | 1 | 2021 | 6570 | 0.06 | Why? |
Female | 11 | 2021 | 380317 | 0.06 | Why? |
Asymptomatic Infections | 1 | 2020 | 7218 | 0.06 | Why? |
Mutation | 1 | 2021 | 12376 | 0.05 | Why? |
Oligodeoxyribonucleotides | 1 | 2021 | 206 | 0.05 | Why? |
Rabies Vaccines | 1 | 2021 | 106 | 0.05 | Why? |
Squalene | 1 | 2021 | 196 | 0.05 | Why? |
Alum Compounds | 1 | 2021 | 210 | 0.05 | Why? |
Lymphoid Tissue | 1 | 2021 | 162 | 0.05 | Why? |
Child, Preschool | 2 | 2021 | 36283 | 0.05 | Why? |
Algorithms | 1 | 2017 | 7346 | 0.05 | Why? |
Clinical Trials, Phase I as Topic | 1 | 2021 | 242 | 0.05 | Why? |
Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
Cytokines | 1 | 2020 | 15010 | 0.04 | Why? |
Young Adult | 4 | 2021 | 93724 | 0.04 | Why? |
Infant | 1 | 2021 | 30274 | 0.04 | Why? |
Adolescent | 4 | 2021 | 86841 | 0.04 | Why? |
Germinal Center | 1 | 2021 | 332 | 0.04 | Why? |
Clinical Trials, Phase II as Topic | 1 | 2021 | 801 | 0.04 | Why? |
Measles-Mumps-Rubella Vaccine | 1 | 2021 | 282 | 0.04 | Why? |
In Vitro Techniques | 1 | 2021 | 1027 | 0.04 | Why? |
Rodentia | 1 | 2018 | 235 | 0.04 | Why? |
Animals, Domestic | 1 | 2018 | 272 | 0.04 | Why? |
Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2021 | 511 | 0.04 | Why? |
Immunity, Humoral | 2 | 2021 | 4849 | 0.04 | Why? |
Glycosylation | 1 | 2020 | 1255 | 0.04 | Why? |
RNA, Viral | 2 | 2021 | 32276 | 0.04 | Why? |
Substrate Specificity | 1 | 2017 | 639 | 0.04 | Why? |
Animals | 3 | 2021 | 78931 | 0.04 | Why? |
Transcription, Genetic | 1 | 2021 | 1326 | 0.04 | Why? |
Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
Coronavirus Infections | 2 | 2020 | 253789 | 0.04 | Why? |
Organoids | 1 | 2021 | 840 | 0.03 | Why? |
Area Under Curve | 1 | 2021 | 2564 | 0.03 | Why? |
California | 1 | 2020 | 2047 | 0.03 | Why? |
Immunization, Secondary | 1 | 2021 | 1649 | 0.03 | Why? |
Viremia | 1 | 2020 | 1020 | 0.03 | Why? |
Ligands | 1 | 2017 | 1300 | 0.03 | Why? |
Sequence Analysis, RNA | 1 | 2021 | 2290 | 0.03 | Why? |
Pandemics | 5 | 2021 | 389249 | 0.03 | Why? |
Animals, Wild | 1 | 2018 | 1028 | 0.03 | Why? |
Macaca mulatta | 1 | 2021 | 3716 | 0.03 | Why? |
Single-Cell Analysis | 1 | 2021 | 2450 | 0.03 | Why? |
Reagent Kits, Diagnostic | 1 | 2021 | 2149 | 0.03 | Why? |
Health Personnel | 1 | 2020 | 29646 | 0.03 | Why? |
Tumor Necrosis Factor-alpha | 1 | 2020 | 2483 | 0.03 | Why? |
Whole Genome Sequencing | 1 | 2021 | 3239 | 0.03 | Why? |
Autoantibodies | 1 | 2021 | 2094 | 0.02 | Why? |
Crystallography, X-Ray | 1 | 2017 | 2689 | 0.02 | Why? |
ROC Curve | 1 | 2021 | 6024 | 0.02 | Why? |
Nanoparticles | 1 | 2021 | 2040 | 0.02 | Why? |
Transcriptome | 1 | 2021 | 3466 | 0.02 | Why? |
Mycobacterium tuberculosis | 1 | 2017 | 1164 | 0.02 | Why? |
Immunity, Cellular | 1 | 2021 | 3614 | 0.02 | Why? |
Evolution, Molecular | 1 | 2021 | 3691 | 0.02 | Why? |
Epitopes, T-Lymphocyte | 1 | 2017 | 2262 | 0.02 | Why? |
CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.02 | Why? |
Amino Acid Sequence | 1 | 2017 | 6049 | 0.02 | Why? |
Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
Specimen Handling | 1 | 2021 | 6190 | 0.02 | Why? |
Models, Molecular | 1 | 2017 | 7616 | 0.02 | Why? |
Interleukin-6 | 1 | 2020 | 7522 | 0.01 | Why? |
Follow-Up Studies | 1 | 2021 | 17020 | 0.01 | Why? |
Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
Phylogeny | 1 | 2018 | 13341 | 0.01 | Why? |
Genome, Viral | 1 | 2021 | 13157 | 0.01 | Why? |
Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
Delivery of Health Care | 1 | 2020 | 15909 | 0.01 | Why? |
United States | 1 | 2021 | 46150 | 0.01 | Why? |
Surveys and Questionnaires | 1 | 2021 | 43792 | 0.01 | Why? |
Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
Child | 1 | 2020 | 70012 | 0.01 | Why? |
Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
Boyd's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(154)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(250)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_